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BACKGROUND
Observational data have shown that slow advancement of enteral feeding volumes 
in preterm infants is associated with a reduced risk of necrotizing enterocolitis but 
an increased risk of late-onset sepsis. However, data from randomized trials are 
limited.
METHODS
We randomly assigned very preterm or very-low-birth-weight infants to daily milk 
increments of 30 ml per kilogram of body weight (faster increment) or 18 ml per 
kilogram (slower increment) until reaching full feeding volumes. The primary 
outcome was survival without moderate or severe neurodevelopmental disability at 
24 months. Secondary outcomes included components of the primary outcome, con-
firmed or suspected late-onset sepsis, necrotizing enterocolitis, and cerebral palsy.
RESULTS
Among 2804 infants who underwent randomization, the primary outcome could 
be assessed in 1224 (87.4%) assigned to the faster increment and 1246 (88.7%) 
assigned to the slower increment. Survival without moderate or severe neurodevel-
opmental disability at 24 months occurred in 802 of 1224 infants (65.5%) assigned 
to the faster increment and 848 of 1246 (68.1%) assigned to the slower increment 
(adjusted risk ratio, 0.96; 95% confidence interval [CI], 0.92 to 1.01; P = 0.16). Late-
onset sepsis occurred in 414 of 1389 infants (29.8%) in the faster-increment group 
and 434 of 1397 (31.1%) in the slower-increment group (adjusted risk ratio, 0.96; 
95% CI, 0.86 to 1.07). Necrotizing enterocolitis occurred in 70 of 1394 infants 
(5.0%) in the faster-increment group and 78 of 1399 (5.6%) in the slower-increment 
group (adjusted risk ratio, 0.88; 95% CI, 0.68 to 1.16).
CONCLUSIONS
There was no significant difference in survival without moderate or severe neuro-
developmental disability at 24 months in very preterm or very-low-birth-weight 
infants with a strategy of advancing milk feeding volumes in daily increments of 
30 ml per kilogram as compared with 18 ml per kilogram. (Funded by the Health 
Technology Assessment Programme of the National Institute for Health Research; 
SIFT Current Controlled Trials number, ISRCTN76463425.)
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I nfants who are very preterm (<32 weeks of gestation) or who have a very low birth weight (<1500 g) are fed increasing vol-
umes of milk per day until they reach full enteral 
feeding volumes. The approach to increasing the 
feeding volume per day is uncertain because of 
competing concerns. Observational studies have 
shown a higher risk of necrotizing enterocolitis1-3 
with rapid advancement of feeding volumes but 
are subject to bias; one was an uncontrolled study 
before and after the introduction of a slowly pro-
gressive tube-feeding schedule,1 and two were 
small case–control studies.2,3 Slower advances in 
feeding volume might, however, increase the risk 
of late-onset sepsis from longer exposure to 
parenteral feeding, as shown in a meta-analysis 
that also revealed no increase in necrotizing 
enterocolitis.4 These conditions are both major 
causes of death and illness, including adverse 
neurodevelopmental outcomes.5-8
Existing trial data are insufficient to deter-
mine whether advancing enteral feeding volumes 
slowly (typically by <24 ml per kilogram of body 
weight per day) as compared with more quickly 
(by 30 to 40 ml per kilogram per day) affects out-
comes of very preterm or very-low-birth-weight 
infants.4,9-16 The Speed of Increasing Milk Feeds 
Trial (SIFT) therefore compared faster (30 ml per 
kilogram) with slower (18 ml per kilogram) daily 
increments in milk feeding volumes.
Me thods
Trial Design and Procedures
The trial was a multicenter, parallel-group, ran-
domized, controlled trial that followed a pub-
lished protocol,17 also available with the full text 
of this article at NEJM.org. The trial was approved 
by the East Midlands National Research Ethics 
Committee and the National Maternity Hospital 
Ethics Committee in Dublin and overseen by in-
dependent steering and data and safety monitor-
ing committees.
Trial Participants
After written informed consent was obtained 
from parents, infants receiving less than 30 ml 
of milk per kilogram per day at randomization 
were eligible to participate if they were born 
before 32 weeks of gestation, had a birth weight 
of less than 1500 g, or both. Infants who had a 
known severe congenital anomaly or no realistic 
chance of survival or who were unlikely to be 
traceable for follow-up were ineligible.
Enrollment and Treatment
When clinicians were ready to start advancing 
feeding volumes, infants were randomly assigned 
to receive daily increments in feeding volume of 
30 ml per kilogram (faster increment) or 18 ml 
per kilogram (slower increment). Computerized 
randomization was performed through a secure 
website hosted by the National Perinatal Epide-
miology Unit Clinical Trials Unit, University of 
Oxford. A minimization algorithm balanced prog-
nostic factors: hospital, multiple birth, gestational 
age range (Table 1), and whether the birth weight 
was below the 10th percentile for gestational age. 
Infants from multiple births were assigned to the 
same treatment. All other aspects of feeding and 
care followed routine clinical practice in the in-
dividual units, including the capacity to stop or 
alter the rate of increase in feeding volume if 
clinically indicated. Data were collected at trial 
entry, including whether the infant had absent 
or reversed end-diastolic umbilical arterial blood 
flow identified on any antenatal ultrasonograph-
ic scan.
Primary and Secondary Outcomes
The primary outcome was survival without mod-
erate or severe neurodevelopmental disability at 
24 months of age, corrected for gestational age 
at birth. Moderate or severe neurodevelopmental 
disability was defined as any of the following: 
moderate or severe visual impairment (reduced 
vision uncorrected with aids, blindness in one 
eye with good vision in the contralateral eye, or 
blindness or light perception only), moderate or 
severe hearing impairment (hearing loss correct-
ed with aids, some hearing loss uncorrected by 
aids, or deafness), moderate or severe gross mo-
tor impairment (inability to walk or sit indepen-
dently), or moderate or severe cognitive impair-
ment as assessed with the use of the Parent 
Report of Children’s Abilities–Revised (PARCA-R) 
or clinical data if PARCA-R scores were missing. 
Total PARCA-R scores of less than 44 (range, 0 to 
158, with lower scores indicating greater impair-
ment) were used to identify children with mod-
erate or severe developmental impairment.18
Secondary outcomes included death, death be-
fore discharge home, microbiologically confirmed 
or clinically suspected late-onset sepsis from trial 
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Characteristic
Faster Increment: 
30 ml/kg/day 
(N = 1394)
Slower Increment: 
18 ml/kg/day 
(N = 1399)
Male sex — no./total no. (%) 739/1394 (53.0) 726/1398 (51.9)
Infant’s median age at randomization (IQR) — days 4 (3–6) 4 (3–6)
Birth weight <10th percentile for gestational age —  
no./total no. (%)
295/1394 (21.2) 291/1398 (20.8)
Gestational age at delivery
Median (IQR) — wk 29 (27–30) 29 (27–30)
Distribution — no. (%)
23 wk 0 days to 25 wk 6 days 205 (14.7) 201 (14.4)
26 wk 0 days to 27 wk 6 days 291 (20.9) 297 (21.2)
28 wk 0 days to 29 wk 6 days 377 (27.0) 383 (27.4)
30 wk 0 days to 31 wk 6 days 432 (31.0) 432 (30.9)
32 wk 0 days to 36 wk 6 days 88 (6.3) 86 (6.1)
≥37 wk 0 days 1 (0.1) 0
Birth weight
Mean — g 1144.2±339.3 1142.3±328.9
Distribution — no. (%)
<500 g 10 (0.7) 7 (0.5)
≥500 to <1000 g 494 (35.4) 509 (36.4)
≥1000 to <1500 g 661 (47.4) 677 (48.4)
≥1500 g 229 (16.4) 206 (14.7)
Infant heart rate >100 beats/min at 5 min — no./total no. (%) 1263/1374 (91.9) 1265/1381 (91.6)
Infant mean worst base excess within 24 hr after birth −6.1±4.0 −6.1±3.9
Infant ventilated through endotracheal tube at randomization  
— no./total no. (%)
316/1392 (22.7) 293/1397 (21.0)
Infant had absent or reversed end-diastolic umbilical flow  
— no./total no. (%)
209/1372 (15.2) 226/1380 (16.4)
Median time from trial entry to first feed (IQR) — days 0 (0–0) 0 (0–1)
Mother’s mean age at randomization — yr 30.5±6.2 30.7±6.2
Multiple pregnancy
Any — no. (%)† 412 (29.6) 411 (29.4)
Singles‡ 3 5
Twins§ 358 359
Triplets¶ 51 47
Cesarean section delivery — no./total no. (%) 841/1393 (60.4) 847/1399 (60.5)
Membranes ruptured >24 hr before delivery — no./total no. (%) 323/1377 (23.5) 338/1380 (24.5)
*  Plus–minus values are means ±SD. Unless otherwise stated, the table gives the percentages of infants with data in that 
group of the trial who had (or whose mother had) the stated characteristic. The number of infants with missing data 
was as follows: for infant worst base excess within 24 hours after birth, 29 in the faster-increment group and 26 in the 
slower-increment group; for time from trial entry to first feed, 5 and 4, respectively; and for mother’s age at randomiza-
tion, 0 and 1. Percentages may not total 100 because of rounding. IQR denotes interquartile range. More details on 
gestational age, birth weight, and other characteristics are provided in Table S7.
†  Sometimes, only one infant from a multiple pregnancy met the inclusion criteria and was recruited.
‡  Shown is the number of infants from multiple pregnancies in which the other fetuses were aborted, miscarried, or stillborn.
§  Shown is the number of infants who were one of twins.
¶  Shown is the number of infants who were one of triplets.
Table 1. Infant and Maternal Characteristics at Trial Entry.*
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entry to discharge home, Bell’s stage 2 or 3 nec-
rotizing enterocolitis (stages range from 1 to 3, 
with higher stages indicating greater severity of 
disease) from trial entry to discharge home, time 
taken to reach full milk feeding volumes (150 ml 
per kilogram per day for 3 consecutive days), 
growth (change in weight and head circumfer-
ence z score for gestational age) from birth to 
discharge home, duration of parenteral feeding, 
duration of time in intensive care, duration of 
hospital stay to discharge home, diagnosis of 
cerebral palsy by a doctor or other health profes-
sional, moderate or severe neurodevelopmental 
disability at 24 months (corrected for gestational 
age), and the individual components of the defi-
nition of moderate or severe neurodevelopmen-
tal disability.
Classifications of moderate or severe neuro-
developmental disability, late-onset sepsis, and 
necrotizing enterocolitis were confirmed by an 
end-point review committee whose members were 
unaware of the trial-group assignments; the com-
mittee used standard definitions if outcomes 
were ambiguous or data were missing (see the 
Supplementary Appendix, available at NEJM.org). 
All data-collection forms were assessed indepen-
dently by pairs of clinicians who were unaware 
of the trial-group assignments. Owing to round-
ing of the feeding rate to the nearest 0.5 ml per 
kilogram or small changes in daily weight in the 
clinical setting, some infants receiving “full en-
teral feeding volumes” received only 145 to 149 ml 
per kilogram per day. We therefore considered 
an infant to be receiving full enteral feeding 
volumes if at least 145 ml per kilogram per day 
was administered for 3 consecutive days. Cases 
that did not meet these criteria were reviewed by 
the end-point review committee to determine 
whether a sustained level of feeding below this 
had been achieved. Examples of this included 
feeds being stopped during transfer or a proce-
dure and use of higher-calorie formula.
Statistical Analysis
We estimated that 80% of infants would survive 
to 2 years and that 11% of survivors would have 
moderate or severe neurodevelopmental disabil-
ity.19 We anticipated that the primary outcome 
would occur in 71% of the comparator (slower-
increment) group. With a total sample size of 2500 
and allowance for a questionnaire response rate 
of 80%, there would be 90% power to detect an 
absolute difference of 6.3 percentage points in 
the incidence of the primary outcome between 
the trial groups with a two-sided significance 
level of 5%. Similarly, enrollment of 2500 infants 
would provide the trial with 90% power to detect 
an absolute difference of 5.4 percentage points 
(from 25.0% in the comparator group) in the 
incidence of late-onset sepsis20 and an absolute 
difference of 3.5 percentage points (from 6.0% in 
the comparator group) in the incidence of necro-
tizing enterocolitis (Bell’s stage 2 or 3).21-23
Subsequently, an inflation factor of 1.12 was 
applied to the sample size to allow for multiple 
births, since infants from a multiple birth received 
the same treatment and we anticipated correlated 
outcomes. This adjustment assumed the percent-
age of multiple births to be 25% and an intra-
class correlation coefficient of 0.9 for the primary 
outcome at 24 months, corrected for gestational 
age.24 The total target sample size was therefore 
increased to 2800.
Demographic factors, clinical characteristics, 
and outcomes were summarized with counts and 
percentages for categorical variables, means and 
standard deviations for normally distributed con-
tinuous variables, and medians and interquartile 
or simple ranges for other continuous variables. 
Outcomes were analyzed on an intention-to-treat 
basis with the use of the slower-increment group 
as the comparator.
Risk ratios and 95% confidence intervals were 
calculated for the primary outcome at 24 months 
(corrected for gestational age) and for the dis-
charge outcomes of late-onset sepsis and necro-
tizing enterocolitis. We used 99% confidence in-
tervals for all other dichotomous outcomes, to 
take account of the number of hypothesis tests 
performed, without full adjustment for multiple 
testing. For normally distributed continuous out-
comes, the mean difference and 99% confidence 
interval are presented; for skewed continuous 
variables, the median difference and 99% confi-
dence interval are presented. Adjusted risk ratios 
were estimated with the use of log-binomial re-
gression, or log-Poisson regression with a robust 
variance estimator if the binomial model failed 
to converge. Linear regression was used for nor-
mally distributed continuous variables, and quan-
tile regression was used for skewed continuous 
variables. The primary inference was based on the 
analysis with adjustment for the minimization 
factors at randomization. Center was fitted as a 
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random effect, and the other minimization fac-
tors were fitted as fixed effects. A unique identi-
fier for each mother was nested within center to 
take account of the additional level of clustering 
due to multiple births and siblings. This method 
facilitates the calculation of robust standard er-
rors to allow for the lack of independence in trial-
group assignments and the potential correlation 
in outcome.
The consistency of the effects of advancing 
milk feeding volumes on the incidence of the pri-
mary outcome, late-onset sepsis, and necrotizing 
enterocolitis across specific subgroups was as-
sessed with the use of the statistical test of in-
teraction. Prespecified subgroup analyses includ-
ed week of gestation at birth, birth weight (<10th 
percentile for gestational age vs. ≥10th percentile), 
and type of milk received during the hospital 
stay (breast milk only vs. formula only vs. both 
breast milk and formula). Post hoc analysis as-
sessed the effect of the increments on late-onset 
sepsis and necrotizing enterocolitis in infants with 
absent or reversed end-diastolic umbilical flow on 
antenatal Doppler ultrasonography. Other devia-
tions from the protocol include the use of quan-
tile regression instead of Cox regression to ana-
lyze the time to full feeding volumes (because 
the Cox proportional-hazards assumption was 
not satisfied) and mixed-effect log-binomial or 
log-Poisson models instead of generalized esti-
mating equations (owing to the ease and flexibil-
ity of these methods, which were not in common 
use when the trial was conceived). We performed 
a sensitivity analysis to examine the effect of 
missing data at 24 months on the primary out-
come, by considering different scenarios that de-
parted from the assumption that data were miss-
ing completely at random.
R esult s
Participants
A total of 2804 infants were recruited between 
June 8, 2013, and June 30, 2015, from 55 hospitals. 
Infant and maternal characteristics were similar 
in the two trial groups (Table 1, and Table S3A 
through S3C in the Supplementary Appendix). 
All infants received the assigned intervention, 
but 69 discontinued the intervention, 66 owing 
to clinician or parental preference and 3 owing 
to transfer to a nonparticipating hospital (Fig. 1). 
For 11 infants, parental consent was withdrawn, 
and their data were not available for analysis. 
The remainder were included in modified inten-
tion-to-treat analyses. Outcome data at discharge 
home were not available for 8 infants; their data 
were included in the analyses, except when knowl-
edge of discharge or the date of discharge was 
required. A total of 68 infants in the faster-incre-
ment group and 77 in the slower-increment group 
died before 24 months, corrected for gestational 
age (Table 2). Assessment of the primary outcome 
at 24 months, corrected for gestational age, was 
possible in 1224 infants (87.4%) in the faster-
increment group and 1246 (88.7%) in the slower-
increment group (Fig. 1).
Primary and Secondary Outcomes at 24 Months 
of Age, Corrected for Prematurity
At 24 months (corrected for gestational age), 
death had occurred in 68 of 1224 infants (5.6%) 
in the faster-increment group and in 77 of 1246 
(6.2%) in the slower-increment group, and mod-
erate or severe neurodevelopmental disability 
had occurred in 354 infants in the faster-incre-
ment group and in 321 in the slower-increment 
group (Table 2). There was no significant differ-
ence between infants receiving a faster daily in-
crement (30 ml per kilogram) and those receiv-
ing a slower daily increment (18 ml per kilogram) 
regarding the primary outcome of survival with-
out moderate or severe neurodevelopmental dis-
ability at 24 months, corrected for gestational 
age (Table 2). There were also no significant 
differences between the faster-increment group 
and the slower-increment group regarding the 
individual components of the composite outcome. 
The results were similar in sensitivity analyses of 
missing data that used different approaches to 
impute missing data (Table S5B).
Secondary Outcomes
The faster-increment group reached full milk feed-
ing volumes at a median of 7 days, as compared 
with 10 days in the slower-increment group (ad-
justed median difference, −2.7 days; 99% confi-
dence interval [CI], −3.1 to −2.4); the duration of 
parenteral nutrition from trial entry to discharge 
home was 9 days and 11 days, respectively (ad-
justed median difference, −2.2 days; 99% CI, −2.7 
to −1.6) (Table 3). There was no evidence of sig-
nificant between-group differences regarding con-
firmed or clinically suspected late-onset sepsis, 
Bell’s stage 2 or 3 necrotizing enterocolitis, death 
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during hospitalization, weight and head circum-
ference standard-deviation scores at discharge, 
duration of time in intensive care, and duration of 
hospital stay from trial entry (Table 3).
After adjustment for minimization factors, 
moderate or severe motor impairment occurred 
in 7.5% of the infants in the faster-increment group 
and 5.0% of those in the slower-increment group 
(adjusted risk ratio, 1.48; 99% CI, 1.02 to 2.14) 
(Table 2). There was no evidence of significant 
between-group differences for the other three 
components of the disability definition.
Subgroup Analyses
There was weak evidence of statistical interac-
tion between the type of milk (breast milk only, 
formula only, or both breast milk and formula) 
and feeding increment with respect to survival 
without moderate or severe neurodevelopmental 
disability at 24 months, corrected for gestational 
age (P = 0.045). For infants fed with formula only, 
survival without moderate or severe neurodevel-
opmental disability was seen in 12 of 30 infants 
(40%) in the faster-increment group, as compared 
with 28 of 40 (70%) in the slower-increment group 
(Fig. 2 and Table S5C). There was no evidence of 
differential treatment effects for any other pre-
specified subgroup from trial entry until discharge 
or at 24 months, corrected for gestational age 
(Fig. 2 and Figs. S2 and S3). Post hoc analysis did 
not show an interaction between antenatal absent 
or reversed end-diastolic umbilical flow and faster 
or slower feeding increments (Tables S1 and S2).
Serious Adverse Events
Four serious adverse events that were not pre-
specified as outcomes were reported. One infant 
in each group had an intracardiac thrombus, with 
one of these extending into the superior vena cava 
and causing renal failure and death (faster-incre-
ment group). One infant (in the faster-increment 
group) had conjugated hyperbilirubinemia, which 
resolved, and one infant (in the slower-increment 
group) became dehydrated briefly with extravasa-
tion from a central venous catheter.
Discussion
In this large, pragmatic, randomized, controlled 
trial involving infants with a gestational age of less 
Figure 1. Randomization, Intervention, and Analysis.
2804 Infants underwent randomization
(2440 mothers) 
1400 Were assigned to faster feeding
increment (30 ml/kg/day)
29 Discontinued intervention
29 Were withdrawn
1404 Were assigned to slower feeding
increment (18 ml/kg/day)
5 Underwent randomization in error
40 Discontinued intervention
37 Were withdrawn
3 Were transferred to nonparticipating
site
5 Had consent
withdrawn
6 Had consent
withdrawn
1394 Were included in analysis
of outcomes at discharge
1399 Were included in analysis
of outcomes at discharge
77 Died before 24 mo
153 Had missing primary-
outcome data
68 Died before 24 mo
170 Had missing primary-
outcome data
1224 Were included in analysis
of primary outcome at 24 mo
(including 68 infants who died)
1246 Were included in analysis
of primary outcome at 24 mo
(including 77 infants who died)
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than 32 weeks or a birth weight of less than 1500 g, 
advancing milk feeding volumes at daily incre-
ments of 30 ml per kilogram as compared with 
18 ml per kilogram did not affect survival without 
moderate or severe neurodevelopmental disability 
at 24 months, corrected for gestational age. The 
speed of increment in feeding volumes also did 
not affect the risks of late-onset sepsis, necrotiz-
ing enterocolitis, or death during hospitalization.
Secondary-outcome analysis suggested that 
the number of days to reach full milk feeding 
volumes and the number of days of parenteral 
nutrition were lower with faster increments than 
with slower increments. Although these feeding 
outcomes seem to favor faster increments, the 
risk of moderate or severe motor impairment was 
unexpectedly higher in the faster-increment group 
than in the slower-increment group. This obser-
Outcome
Faster Increment: 
30 ml/kg/day 
(N = 1394)
Slower Increment: 
18 ml/kg/day 
(N = 1399)
Unadjusted Effect 
Measure (CI)†
Adjusted Effect 
Measure (CI)†‡
Primary outcome
Survival without moderate or severe neurodevelop-
mental disability — no./total no. (%)§¶
802/1224 (65.5) 848/1246 (68.1) 0.96 (0.91 to 1.02) 0.96 (0.92 to 1.01)
Survival — no. (%) 1326 (95.1) 1322 (94.5) 1.01 (0.99 to 1.02) 1.01 (0.99 to 1.03)
Moderate or severe neurodevelopmental dis-
ability — no./total no. (%)
354/1156 (30.6) 321/1169 (27.5) 1.12 (0.98 to 1.28) 1.10 (0.97 to 1.25)
Secondary outcomes
Moderate or severe visual impairment  
— no./total no. (%)
21/1156 (1.8) 16/1171 (1.4) 1.33 (0.57 to 3.10) 1.28 (0.43 to 3.83)
Moderate or severe hearing impairment  
— no./total no. (%)
58/1143 (5.1) 41/1172 (3.5) 1.45 (0.86 to 2.46) 1.43 (0.79 to 2.57)
Moderate or severe motor impairment  
— no./total no. (%)
87/1164 (7.5) 59/1177 (5.0) 1.49 (0.96 to 2.32) 1.48 (1.02 to 2.14)
Moderate or severe cognitive impairment  
— no./total no. (%)
307/1156 (26.6) 289/1170 (24.7) 1.08 (0.89 to 1.30) 1.06 (0.89 to 1.27)
PARCA-R‖
Mean composite score 72.5±38.3 73.9±37.8 −1.5 (−6.3 to 3.4) −0.6 (−4.8 to 3.6)
Mean score on Nonverbal Cognition Scale 25.1±6.2 25.5±5.7 −0.5 (−1.2 to 0.3) −0.4 (−1.0 to 0.3)
Mean score on Vocabulary Subscale 39.3±29.7 40.3±30.1 −1.0 (−4.8 to 2.8) −0.4 (−3.7 to 3.0)
Mean score on Sentence Complexity Subscale 7.9±5.7 7.9±5.4 −0.1 (−0.8 to 0.6) −0.1 (−0.7 to 0.6)
Diagnosis of cerebral palsy by a doctor or other 
health professional — no./total no. (%)
58/1084 (5.4) 35/1099 (3.2) 1.68 (0.97 to 2.91) 1.66 (0.97 to 2.84)
*  Plus–minus values are means ±SD. CI denotes confidence interval.
†  Risk ratios are shown for binary outcomes, and mean differences are shown for continuous outcomes. Shown are 95% confidence intervals 
for survival without moderate or severe neurodevelopmental disability, survival, and moderate or severe neurodevelopmental disability and 
99% confidence intervals for all other outcomes. The 99% confidence intervals have not been fully adjusted for multiple comparisons and 
should not be used to infer definitive treatment effects.
‡  According to a prespecified plan, the effect measure was adjusted for minimization factors — collaborating hospital, single or multiple 
birth, gestational age at birth, and whether the birth weight was below the 10th percentile for gestational age — when technically possible.
§  P = 0.16 for testing whether adjusted risk ratio is equal to 1.
¶  Moderate or severe neurodevelopmental disability was defined as one or more of the following: moderate or severe visual impairment, 
moderate or severe hearing impairment, moderate or severe motor impairment, or moderate or severe cognitive impairment. Moderate or 
severe visual, hearing, and motor impairments were defined according to the British Association of Perinatal Medicine.25 Moderate or severe 
cognitive impairment was defined by a composite score on the Parent Report of Children’s Abilities–Revised (PARCA-R) of less than 44 
(range, 0 to 158, with lower scores indicating greater impairment).
‖  Scores on the Nonverbal Cognition Scale range from 0 to 34, scores on the Vocabulary Subscale range from 0 to 100, and scores on the 
Sentence Complexity Subscale range from 0 to 24; on all scales, lower scores indicate greater impairment. The number of infants with miss-
ing data was as follows: for composite score, 419 in the faster-increment group and 392 in the slower-increment group; for score on the 
Nonverbal Cognition Scale, 414 and 390, respectively; for score on the Vocabulary Subscale, 412 and 383; and for score on the Sentence 
Complexity Subscale, 405 and 379.
Table 2. Primary and Secondary Outcomes at 24 Months of Age, Corrected for Gestational Age.*
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vation is unexplained, and there were not more 
cases of late-onset sepsis or necrotizing entero-
colitis in the faster-increment group. It is possible 
that it is a chance finding, since it was one of 
multiple secondary outcomes assessed, but bio-
logically plausible explanations include increased 
cardiorespiratory events from pressure on the dia-
phragm or inability to absorb enteral nutrition.
The trial was pragmatic, and, apart from daily 
increments in milk volume, clinician preference 
and unit guidelines determined other care. The 
primary outcome could be assessed in 87.4% of 
the infants in the faster-increment group and in 
88.7% of those in the slower-increment group at 
24 months, corrected for gestational age. Similar 
results were obtained from sensitivity analyses 
with imputation of missing data.
As compared with previous trials,9-16 the pres-
ent trial included larger numbers of high-risk in-
fants, including 1020 extremely low-birth-weight 
infants (<1000 g), 994 extremely preterm infants 
(<28 weeks of gestation), and 435 infants with 
absent or reversed end-diastolic umbilical flow 
on antenatal Doppler studies. Subgroup analyses 
of higher-risk infants were reassuring, because 
there was no suggestion of worse outcomes with 
faster increments than with slower increments. 
Infants were a median of 4 days old at commence-
ment of the intervention, and therefore the trial 
does not inform the relative safety of these feed-
Outcome
Faster Increment: 
30 ml/kg/day 
(N = 1394)
Slower Increment: 
18 ml/kg/day 
(N = 1399)
Unadjusted Effect 
Measure (CI)†
Adjusted Effect 
Measure (CI)†‡
Key discharge outcomes
Microbiologically confirmed or clinically suspected 
late-onset sepsis — no./total no. (%)
414/1389 (29.8) 434/1397 (31.1) 0.96 (0.85 to 1.08) 0.96 (0.86 to 1.07)
Necrotizing enterocolitis, Bell’s stage 2 or 3 — no. (%) 70 (5.0) 78 (5.6) 0.90 (0.66 to 1.24) 0.88 (0.68 to 1.16)
Secondary outcomes
Death before discharge — no./total no. (%) 60/1392 (4.3) 65/1393 (4.7) 0.92 (0.59 to 1.45) 0.91 (0.55 to 1.53)
Median time to reach full milk feeding volumes 
(IQR) — days
7 (7 to 10) 10 (9 to 13) −3.0 (−3.3 to −2.7) −2.7 (−3.1 to −2.4)
Mean weight standard-deviation score at dis-
charge home§
−1.5±1.1 −1.5±1.1 −0.04 (−0.15 to 0.08) −0.02 (−0.11 to 0.08)
Mean head circumference standard-deviation 
score at discharge home§
−0.8±1.5 −0.7±1.7 −0.09 (−0.27 to 0.09) −0.07 (−0.24 to 0.10)
Median duration of parenteral feeding from trial 
entry to discharge home (IQR) — days
9 (7 to 14) 11 (9 to 16) −2.0 (−2.4 to −1.6) −2.2 (−2.7 to −1.6)
Median length of time in intensive care from trial 
entry to discharge home (IQR) — days
7 (4 to 21) 8 (4 to 21) −1.0 (−2.6 to 0.6) −0.4 (−1.5 to 0.6)
Median length of hospital stay from trial entry to 
discharge home (IQR) — days¶
54 (37 to 81) 55 (38 to 78) −1.0 (−5.2 to 3.2) 0.1 (−1.9 to 2.0)
*  Plus–minus values are means ±SD. The number of infants with missing data was as follows: for time to reach full milk feeding volumes 
(145 ml per kilogram per day for 3 consecutive days), 72 in the faster-increment group and 102 in the slower-increment group; for weight 
standard-deviation score at discharge home, 75 and 77, respectively; for head circumference standard-deviation score at discharge home, 
258 and 228; for duration of parenteral feeding from trial entry to discharge home, 10 and 21; for length of time in intensive care from trial 
entry to discharge home, 71 and 87; and for length of hospital stay from trial entry to discharge home, 62 and 71.
†  Risk ratios are shown for binary outcomes, and median or mean differences are shown for continuous outcomes. Shown are 95% confi-
dence intervals for late-onset sepsis and necrotizing enterocolitis (Bell’s stage 2 or 3; stages range from 1 to 3, with higher stages indicating 
greater severity of disease) and 99% confidence intervals for all other outcomes. The 99% confidence intervals have not been fully adjusted 
for multiple comparisons and should not be used to infer definitive treatment effects.
‡  According to a prespecified plan, the effect measure was adjusted for minimization factors — collaborating hospital, single or multiple 
birth, gestational age at birth, and whether the birth weight was below the 10th percentile for gestational age — when technically possible.
§  Scores were calculated with the use of the British 1990 growth reference (revised September 2009). The standard-deviation scores indicate 
how far an infant is from the population mean weight and head circumference for infants of the same age and sex. For example, infants 
with a standard-deviation score of −2 or less compare approximately with the bottom 2% of the reference population.
¶  The analysis included data from surviving infants only.
Table 3. Outcomes at Discharge to Home.*
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ing volume increments in the first few days after 
birth. Further study would be needed to address 
enteral feeding in these infants, other speeds of 
advancing feeding volumes, and different milks. 
Infants born at extremely early gestational ages 
or with an extremely low birth weight may react 
differently than other infants to the speed of in-
creasing feeding volumes. We did not find ap-
preciable differences in outcome according to 
these variables, but our trial included relatively 
small numbers of infants in these categories, and 
further research may be warranted in these groups.
Observational data have suggested a reduced 
risk of necrotizing enterocolitis among very pre-
term or very-low-birth-weight infants fed breast 
milk.26 Most participating infants in SIFT were 
fed, at least partially, with breast milk. Only 2.8% 
of the infants who were followed to 24 months 
were fed formula alone, with similar numbers in 
the two groups. With respect to these formula-
only infants, the finding of a poorer outcome in 
the faster-increment group than in the slower-
increment group probably represents a chance 
finding, given the small numbers of infants, sub-
stantial loss to follow-up, and multiple compari-
sons performed without adjustment for multiple 
testing. The risk–benefit balance of enteral-feed-
ing strategies may differ between human milk–fed 
infants and formula-fed infants.
The trial was unblinded, because it was con-
sidered impractical for caregivers and parents to 
be unaware of the trial-group assignments. This 
is unlikely to have influenced the ascertainment 
of the most important outcomes, which were 
reviewed by end-point review committees whose 
members were unaware of the trial-group assign-
ments. Although it is possible that knowledge of 
the trial-group assignments could alter clinician 
practice (e.g., preferentially stopping feeds given 
at faster rather than slower increments in cases 
of suspected necrotizing enterocolitis), this is 
unlikely to have substantively affected the results.
In conclusion, the speed of advancing enteral 
feeding volumes — daily increments of 30 ml 
per kilogram as compared with 18 ml per kilo-
gram — did not have a significant effect on the 
primary outcome of survival without moderate 
or severe neurodevelopmental disability, nor did 
Figure 2. Subgroup Analyses for the Primary Outcome.
The primary outcome was survival without moderate or severe neurodevelopmental disability at 24 months of age, corrected for gesta-
tional age. P values for interaction were adjusted for minimization factors — collaborating hospital, single or multiple birth, gestational 
age at birth, and whether the birth weight was below the 10th percentile for gestational age — when technically possible. P values and 
confidence intervals were not adjusted for multiple comparisons and should not be used to infer definitive treatment effects.
0.50 1.00 4.002.00
Faster Increment
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Slower Increment
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24 wk 0 days to 24 wk 6 days
25 wk 0 days to 25 wk 6 days
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1.04 (0.92–1.17)
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it affect the risks of late-onset sepsis or necrotiz-
ing enterocolitis in very preterm or very-low-birth-
weight infants.
This article presents independent research commissioned by 
the National Institute for Health Research (NIHR). The views 
and opinions expressed herein are those of the authors and do 
not necessarily reflect those of the National Health Service; the 
NIHR; the NIHR Evaluation, Trials, and Studies Coordinating 
Centre; the Health Technology Assessment Programme; or the 
Department of Health.
Supported by the Health Technology Assessment Programme 
of the National Institute for Health Research.
Disclosure forms provided by the authors are available with 
the full text of this article at NEJM.org.
A data sharing statement provided by the authors is available 
with the full text of this article at NEJM.org.
We thank all the families, infants, and hospital staff who 
participated in the trial.
References
1. Brown EG, Sweet AY. Preventing nec-
rotizing enterocolitis in neonates. JAMA 
1978; 240: 2452-4.
2. Henderson G, Craig S, Brocklehurst P, 
McGuire W. Enteral feeding regimens and 
necrotising enterocolitis in preterm infants: 
a multicentre case-control study. Arch Dis 
Child Fetal Neonatal Ed 2009; 94: F120-
F123.
3. McKeown RE, Marsh TD, Amarnath 
U, et al. Role of delayed feeding and of 
feeding increments in necrotizing entero-
colitis. J Pediatr 1992; 121: 764-70.
4. Morgan J, Young L, McGuire W. Slow 
advancement of enteral feed volumes to 
prevent necrotising enterocolitis in very 
low birth weight infants. Cochrane Data-
base Syst Rev 2015; 10: CD001241.
5. Berrington JE, Hearn RI, Bythell M, 
Wright C, Embleton ND. Deaths in pre-
term infants: changing pathology over 
2 decades. J Pediatr 2012; 160(1): 49-53.e1.
6. Moore T, Hennessy EM, Myles J, et al. 
Neurological and developmental outcome 
in extremely preterm children born in 
England in 1995 and 2006: the EPICure 
studies. BMJ 2012; 345: e7961.
7. Schlapbach LJ, Aebischer M, Adams 
M, et al. Impact of sepsis on neurodevel-
opmental outcome in a Swiss national 
cohort of extremely premature infants. 
Pediatrics 2011; 128(2): e348-e357.
8. Johnson S, Hollis C, Kochhar P, Hen-
nessy E, Wolke D, Marlow N. Psychiatric 
disorders in extremely preterm children: 
longitudinal finding at age 11 years in the 
EPICure study. J Am Acad Child Adolesc 
Psychiatry 2010; 49(5): 453-63.e1.
9. Caple J, Armentrout D, Huseby V, et 
al. Randomized, controlled trial of slow 
versus rapid feeding volume advancement 
in preterm infants. Pediatrics 2004; 114: 
1597-600.
10. Karagol BS, Zenciroglu A, Okumus N, 
Polin RA. Randomized controlled trial of 
slow vs rapid enteral feeding advance-
ments on the clinical outcomes of pre-
term infants with birth weight 750-1250 g. 
JPEN J Parenter Enteral Nutr2013; 37: 
223-8.
11. Krishnamurthy S, Gupta P, Debnath 
S, Gomber S. Slow versus rapid enteral 
feeding advancement in preterm newborn 
infants 1000-1499 g: a randomized con-
trolled trial. Acta Paediatr 2010; 99: 42-6.
12. Modi M, Ranji S, Jain A, Sharma P, 
Gupta N. A randomised trial of aggressive 
feeding regimen in infants with birth-
weight ≤1250 grams. Presented at the An-
nual Meeting of the Pediatric Academic 
Societies, San Diego, CA, April 25–28, 
2015. abstract.
13. Jain S, Mukhopadhyay K, Jain V, Ku-
mar P. Slow versus rapid enteral feed in 
preterm neonates with antenatal absent 
end diastolic flow. J Matern Fetal Neona-
tal Med 2016; 29: 2828-33.
14. Rayyis SF, Ambalavanan N, Wright L, 
Carlo WA. Randomized trial of “slow” 
versus “fast” feed advancements on the 
incidence of necrotizing enterocolitis in 
very low birth weight infants. J Pediatr 
1999; 134: 293-7.
15. Salhotra A, Ramji S. Slow versus fast 
enteral feed advancement in very low 
birth weight infants: a randomized con-
trol trial. Indian Pediatr 2004; 41: 435-41.
16. Raban S, Santhakumaran S, Keraan 
Q, et al. A randomised controlled trial of 
high vs low volume initiation and rapid vs 
slow advancement of milk feeds in infants 
with birthweights ≤1000 g in a resource-
limited setting. Paediatr Int Child Health 
2016; 36: 288-95.
17. Abbott J, Berrington J, Bowler U, et al. 
The speed of increasing milk feeds: a ran-
domised controlled trial. BMC Pediatr 
2017; 17: 39.
18. Johnson S, Wolke D, Marlow N. De-
velopmental assessment of preterm in-
fants at 2 years: validity of parent reports. 
Dev Med Child Neurol 2008; 50: 58-62.
19. Mangham LJ, Petrou S, Doyle LW, 
Draper ES, Marlow N. The cost of preterm 
birth throughout childhood in England 
and Wales. Pediatrics 2009; 123(2): e312-
e327.
20. Vermont Oxford Network. Vermont 
Oxford Network Database: data for 31 
neonatal units in the United Kingdom. 
2011 (https://public .vtoxford .org/ data - and 
- reports/ ).
21. Kamoji VM, Dorling JS, Manktelow B, 
Draper ES, Field DJ. Antenatal umbilical 
Doppler abnormalities: an independent 
risk factor for early onset neonatal necro-
tizing enterocolitis in premature infants. 
Acta Paediatr 2008; 97: 327-31.
22. Neu J, Walker WA. Necrotizing en-
terocolitis. N Engl J Med 2011; 364: 255-
64.
23. Holman RC, Stoll BJ, Curns AT, Yorita 
KL, Steiner CA, Schonberger LB. Necro-
tising enterocolitis hospitalisations among 
neonates in the United States. Paediatr 
Perinat Epidemiol 2006; 20: 498-506.
24. Johnson S, Evans TA, Draper ES, et al. 
Neurodevelopmental outcomes following 
late and moderate prematurity: a popula-
tion-based cohort study. Arch Dis Child 
Fetal Neonatal Ed 2015; 100: F301-F308.
25. British Association of Perinatal Medi-
cine. Report of a BAPM/RCPCH Working 
Group: classification of health status at 
2 years as a perinatal outcome. January 8, 
2008 (https://www .networks .nhs .uk/ nhs 
- networks/ staffordshire - shropshire - and 
- black - country - newborn/ documents/ 
2_year_Outcome_BAPM_WG_report 
_v6_Jan08 .pdf).
26. Lucas A, Cole TJ. Breast milk and neo-
natal necrotising enterocolitis. Lancet 1990; 
336: 1519-23.
Copyright © 2019 Massachusetts Medical Society.
The New England Journal of Medicine 
Downloaded from nejm.org by Kirsty Hatton on December 6, 2019. For personal use only. No other uses without permission. 
 Copyright © 2019 Massachusetts Medical Society. All rights reserved. 
